Venetoclax is an anti-cancer medication used to treat certain types of leukemia, such as chronic lymphocytic leukemia (CLL), by inhibiting the Bcl-2 protein. This compound is a chemical intermediate employed to synthesize the drug Venetoclax.
1-((4′-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-(1,1′-biphenyl)-2-yl)methyl)piperazine dihydrochloride
| API Name | Venetoclax |
|---|---|
| CAS No | 1628047-87-9 |
| Molecular Formula | C19H29Cl3N2 |
| Molecular Weight | 391.8 g/mol |
| Synonyms | 1-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazine;dihydrochloride |
Zoho Contact Form
"*" indicates required fields